Phase I Trial of an Investigational Small Pox Medication
NCT00728689
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Orthopoxviral Disease
Smallpox
Monkey Pox
Interventions
DRUG:
ST-246 Days 1 - 3
DRUG:
ST-246 Days 11 - 13
Sponsor
SIGA Technologies
Collaborators
[object Object]